Tumor DNA methylation subtypes predict immunotherapy outcomes in pleural mesothelioma patients in the NIBIT-EPI-MESO study

Nature Genetics 2026

View at publisher
Authors: Luana Calabrò, Francesca P. Caruso, Alessia Covre, Teresa M. R. Noviello, Maria F. Lofiego, Rossella Tufano, Luigi Ferraro, Piera Grisolia, Antonio De Falco, Vincenzo Lagano, Francesco Sgambelluri, Giovanna Sabella
+19 more Giulia Rossi, Giulia Gibilisco, Francesco Marzani, Emma Bello, Elena Simonetti, Vincenzo D’Alonzo, Michele Caraglia, Sandra Coral, Antonina De Angelis, Luigi Cerbone, Sara Delfanti, Diana Giannarelli, Federica Grosso, Anna Maria Di Giacomo, Massimo Milione, Roberta Mortarini, Andrea Anichini, Michele Ceccarelli, Michele Maio
DOI: 10.1038/s41588-026-02580-4
Cited by: 1
References: 74

Fields of Study & Subjects

Occupational and environmental lung diseases Cancer Immunotherapy and Biomarkers Pleural and Pulmonary Diseases

Publication details

Journal / source
Nature Genetics
Publisher
Springer Science and Business Media LLC
Volume
58
Issue
5
Pages
1100–1111
Publication date
27 April 2026
Language
EN